Promoter CpG island hypermethylation during breast cancer progression

Virchows Archiv

Volumn 458, Issue 1, 2011, Pages 73-84

  Park, So Yeon ^a,b   Kwon, Hyeong Ju ^a   Lee, Hee Eun ^a   Ryu, Han Suk ^b   Kim, Sung Won ^b   Kim, Jee Hyun ^b   Kim, In Ah ^b   Jung, Namhee ^c   Cho, Nam Yun ^c   Kang, Gyeong Hoon ^a,c  

^a Seoul National University College of Medicine   (South Korea)

^b Seoul National University Bundang Hospital   (South Korea)

^c Seoul National University   (South Korea)

Author keywords

Breast cancer; CpG islands; Methylation; Tumor progression

Indexed keywords

APC PROTEIN; ESTROGEN RECEPTOR; GLUTATHIONE TRANSFERASE P1; KI 67 ANTIGEN; METALLOTHIONEIN; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2B; PROGESTERONE RECEPTOR; PROTEIN P53; RAS ASSOCIATION DOMAIN FAMILY PROTEIN 1A; RETINOIC ACID RECEPTOR BETA; SECRETED FRIZZLED RELATED PROTEIN 1; SECRETED FRIZZLED RELATED PROTEIN 4; SOMATOMEDIN B; TRANSCRIPTION FACTOR HOXA10; TRANSCRIPTION FACTOR RUNX3;

ADULT; AGED; ARTICLE; BREAST; BREAST CANCER; CANCER GROWTH; CANCER STAGING; CARCINOMA IN SITU; CONTROLLED STUDY; CPG ISLAND; DISEASE CLASSIFICATION; DNA METHYLATION; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN TISSUE; HYPERPLASIA; INTRADUCTAL CARCINOMA; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

ADULT; AGED; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, INTRADUCTAL, NONINFILTRATING; CPG ISLANDS; DISEASE PROGRESSION; DNA METHYLATION; DNA, NEOPLASM; FEMALE; HOMEODOMAIN PROTEINS; HUMANS; HYPERPLASIA; MEMBRANE PROTEINS; METALLOTHIONEIN; MIDDLE AGED; NEOPLASM PROTEINS; PROMOTER REGIONS, GENETIC; PROTO-ONCOGENE PROTEINS; RECEPTORS, N-METHYL-D-ASPARTATE; RETROSPECTIVE STUDIES; TRANSCRIPTION FACTORS; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEINS;

EID: 78651313568     PISSN: 09456317     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00428-010-1013-6     Document Type: Article

References (47)

1. MW Beckmann D Niederacher HG Schnürch BA Gusterson HG Bender 1997 Multistep carcinogenesis of breast cancer and tumour heterogeneity J Mol Med 75 429 439 1:CAS:528:DyaK2sXks1CjurY%3D 10.1007/s001090050128 9231883 (Pubitemid 27297013)
2. WD Dupont DL Page 1985 Risk factors for breast cancer in women with proliferative breast disease N Engl J Med 312 146 151 1:STN:280: DyaL2M%2Fos1Wguw%3D%3D 10.1056/NEJM198501173120303 3965932
3. Tavassoli FA, Hoefler H, Rosai J, Holland R, Ellis IO, Schnitt SJ, Boecker W, Heywang-Köbrunner SH, Moinfar F, Lakhani SR (2003) Intraductal proliferative lesions. In: Tavassoli FA, Delvilee P (eds) World Health Organization classification of tumors: pathology and genetics of tumours of the breast and female genital organs. IARC, Lyon, pp 63-73
4. Schnitt SJ, Collins LC (2009) Columnar cell lesions and flat epithelial atypia. In: Biopsy interpretation of the breast. Lippincott Williams & Wilkins, Philadelphia, pp 96-122
5. M Esteller PG Corn SB Baylin JG Herman 2001 A gene hypermethylation profile of human cancer Cancer Res 61 3225 3229 1:CAS:528:DC%2BD3MXjtFSjt7g%3D 11309270
6. JF Costello MC Frühwald DJ Smiraglia LJ Rush GP Robertson X Gao FA Wright JD Feramisco P Peltomäki JC Lang DE Schuller L Yu CD Bloomfield MA Caligiuri A Yates R Nishikawa H Su Huang NJ Petrelli X Zhang MS O'Dorisio WA Held WK Cavenee C Plass 2000 Aberrant CpG-island methylation has non-random and tumour-type-specific patterns Nat Genet 24 132 138 1:CAS:528: DC%2BD3cXhtFCgsb0%3D 10.1038/72785 10655057 (Pubitemid 30094712)
7. M Widschwendter PA Jones 2002 DNA methylation and breast carcinogenesis Oncogene 21 5462 5482 1:CAS:528:DC%2BD38XlslSqt7k%3D 10.1038/sj.onc.1205606 12154408 (Pubitemid 34983482)
8. CB Umbricht E Evron E Gabrielson A Ferguson J Marks S Sukumar 2001 Hypermethylation of 14-3-3 sigma (stratifin) is an early event in breast cancer Oncogene 20 3348 3353 1:CAS:528:DC%2BD3MXltVSqsbY%3D 10.1038/sj.onc.1204438 11423985 (Pubitemid 32588983)
9. U Lehmann F Länger H Feist S Glöckner B Hasemeier H Kreipe 2002 Quantitative assessment of promoter hypermethylation during breast cancer development Am J Pathol 160 605 612 1:CAS:528:DC%2BD38XitVCkt7w%3D 11839581
10. L Pasquali A Bedeir S Ringquist A Styche R Bhargava G Trucco 2007 Quantification of CpG island methylation in progressive breast lesions from normal to invasive carcinoma Cancer Lett 257 136 144 1:CAS:528: DC%2BD2sXhtFSnt7vO 10.1016/j.canlet.2007.07.010 17706863 (Pubitemid 47464705)
11. JS Lee MJ Fackler WW Teo JH Lee C Choi MH Park JH Yoon Z Zhang P Argani S Sukumar 2008 Quantitative promoter hypermethylation profiles of ductal carcinoma in situ in North American and Korean women: potential applications for diagnosis Cancer Biol Ther 7 1398 1406 1:CAS:528:DC%2BD1cXhsVKms7zE 18769130
12. JS Lee 2007 GSTP1 promoter hypermethylation is an early event in breast carcinogenesis Virchows Arch 450 637 642 1:CAS:528:DC%2BD2sXmvVygt7k%3D 10.1007/s00428-007-0421-8 17479284 (Pubitemid 46986235)
13. T Liu Y Niu Y Feng R Niu Y Yu A Lv Y Yang 2008 Methylation of CpG islands of p16(INK4a) and cyclinD1 overexpression associated with progression of intraductal proliferative lesions of the breast Hum Pathol 39 1637 1646 1:CAS:528:DC%2BD1cXht1Kns7jP 10.1016/j.humpath.2008.04.001 18657295
14. P Lo J Mehrotra A D'Costa MJ Fackler E Garrett-Mayer P Argani S Sukumar 2006 Epigenetic suppression of secreted frizzled related protein 1 (SFRP1) expression in human breast cancer Cancer Biol Ther 5 281 286 1:CAS:528:DC%2BD28XntlWku70%3D 10.4161/cbt.5.3.2384 16410723
15. MO Hoque M Prencipe ML Poeta R Barbano VM Valori M Copetti AP Gallo M Brait E Maiello A Apicella R Rossiello F Zito T Stefania A Paradiso M Carella B Dallapiccola R Murgo I Carosi M Bisceglia VM Fazio D Sidransky P Parrella 2009 Changes in CpG islands promoter methylation patterns during ductal breast carcinoma progression Cancer Epidemiol Biomark Prev 18 2694 2700 1:CAS:528:DC%2BD1MXht1OiurnN 10.1158/1055-9965.EPI-08-0821
16. MM Subramaniam JY Chan R Soong K Ito Y Ito KG Yeoh M Salto-Tellez TC Putti 2009 RUNX3 inactivation by frequent promoter hypermethylation and protein mislocalization constitute an early event in breast cancer progression Breast Cancer Res Treat 113 113 121 1:CAS:528:DC%2BD1cXhsFWrs7nE 10.1007/s10549-008- 9917-4 18256927
17. AA Muggerud JA Rønneberg F Wärnberg J Botling F Busato J Jovanovic H Solvang I Bukholm A Børresen-Dale VN Kristensen T Sørlie J Tost 2010 Frequent aberrant DNA methylation of ABCB1, FOXC1, PPP2R2B and PTEN in ductal carcinoma in situ and early invasive breast cancer Breast Cancer Res 12 R3 10.1186/bcr2466 20056007
18. DJ Weisenberger M Campan TI Long M Kim C Woods E Fiala M Ehrlich PW Laird 2005 Analysis of repetitive element DNA methylation by MethyLight Nucleic Acids Res 33 6823 6836 1:CAS:528:DC%2BD2MXhtlagtbfO 10.1093/nar/gki987 16326863 (Pubitemid 41830488)
19. DJ Weisenberger KD Siegmund M Campan J Young TI Long MA Faasse GH Kang M Widschwendter D Weener D Buchanan H Koh L Simms M Barker B Leggett J Levine M Kim AJ French SN Thibodeau J Jass R Haile PW Laird 2006 CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer Nat Genet 38 787 793 1:CAS:528:DC%2BD28XmtFyqsr8%3D 10.1038/ng1834 16804544 (Pubitemid 43980599)
20. GH Kang S Lee N Cho T Gandamihardja TI Long DJ Weisenberger M Campan PW Laird 2008 DNA methylation profiles of gastric carcinoma characterized by quantitative DNA methylation analysis Lab Invest 88 161 170 1:CAS:528: DC%2BD1cXhtVCrurk%3D 10.1038/labinvest.3700707 18158559 (Pubitemid 351161274)
21. S Ogino T Kawasaki M Brahmandam M Cantor GJ Kirkner D Spiegelman GM Makrigiorgos DJ Weisenberger PW Laird M Loda CS Fuchs 2006 Precision and performance characteristics of bisulfite conversion and real-time PCR (MethyLight) for quantitative DNA methylation analysis J Mol Diagn 8 209 217 1:CAS:528:DC%2BD28XltlKlsrg%3D 10.2353/jmoldx.2006.050135 16645207 (Pubitemid 43811244)
22. JM Harvey GM Clark CK Osborne DC Allred 1999 Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer J Clin Oncol 17 1474 1481 1:STN:280:DyaK1M3msFOjsA%3D%3D 10334533
23. CL Hyun HE Lee KS Kim S Kim JH Kim G Choe SY Park 2008 The effect of chromosome 17 polysomy on HER-2/neu status in breast cancer J Clin Pathol 61 317 321 1:STN:280:DC%2BD1c7ksVSmsA%3D%3D 10.1136/jcp.2007.050336 17761736 (Pubitemid 351354237)
24. JS Lee P Lo MJ Fackler P Argani Z Zhang E Garrett-Meyer S Sukumar 2007 A comparative study of Korean with Caucasian breast cancer reveals frequency of methylation in multiple genes correlates with breast cancer in young, ER, PR-negative breast cancer in Korean women Cancer Biol Ther 6 1114 1120 1:CAS:528:DC%2BD2sXhsVWksrfE 10.1158/1535-7163.MCT-07-0002 17611401 (Pubitemid 350058157)
25. H Shigematsu M Suzuki T Takahashi K Miyajima S Toyooka N Shivapurkar GE Tomlinson D Mastrangelo HI Pass E Brambilla UG Sathyanarayana B Czerniak T Fujisawa N Shimizu A Gazdar 2005 Aberrant methylation of HIN-1 (high in normal-1) is a frequent event in many human malignancies Int J Cancer 113 600 604 1:CAS:528:DC%2BD2MXms1Gn 10.1002/ijc.20622 15472908 (Pubitemid 40038736)
26. N Bloushtain-Qimron J Yao EL Snyder M Shipitsin LL Campbell SA Mani M Hu H Chen V Ustyansky JE Antosiewicz P Argani MK Halushka JA Thomson P Pharoah A Porgador S Sukumar R Parsons AL Richardson MR Stampfer RS Gelman T Nikolskaya Y Nikolsky K Polyak 2008 Cell type-specific DNA methylation patterns in the human breast Proc Natl Acad Sci USA 105 14076 14081 1:CAS:528:DC%2BD1cXhtFKiurjN 10.1073/pnas.0805206105 18780791
27. IE Krop D Sgroi DA Porter KL Lunetta R LeVangie P Seth CM Kaelin E Rhei M Bosenberg S Schnitt JR Marks Z Pagon D Belina J Razumovic K Polyak 2001 HIN-1, a putative cytokine highly expressed in normal but not cancerous mammary epithelial cells Proc Natl Acad Sci USA 98 9796 9801 1:CAS:528: DC%2BD3MXmtlCms7k%3D 10.1073/pnas.171138398 11481438 (Pubitemid 32769383)
28. GH Kang S Lee J Kim H Jung 2003 Profile of aberrant CpG island methylation along multistep gastric carcinogenesis Lab Invest 83 519 526 1:CAS:528:DC%2BD3sXisFCjsb4%3D 12695555 (Pubitemid 36457706)
29. GH Kang S Lee HJ Lee K Hwang 2004 Aberrant CpG island hypermethylation of multiple genes in prostate cancer and prostatic intraepithelial neoplasia J Pathol 202 233 240 1:CAS:528:DC%2BD2cXhvVKjtL8%3D 10.1002/path.1503 14743506 (Pubitemid 38208661)
30. S Lee HJ Lee J Kim H Lee JJ Jang GH Kang 2003 Aberrant CpG island hypermethylation along multistep hepatocarcinogenesis Am J Pathol 163 1371 1378 1:CAS:528:DC%2BD3sXotlegtr0%3D 14507645 (Pubitemid 37175085)
31. DC Allred Y Wu S Mao ID Nagtegaal S Lee CM Perou SK Mohsin P O'Connell A Tsimelzon D Medina 2008 Ductal carcinoma in situ and the emergence of diversity during breast cancer evolution Clin Cancer Res 14 370 378 1:CAS:528: DC%2BD1cXhtVKitrs%3D 10.1158/1078-0432.CCR-07-1127 18223211 (Pubitemid 351226103)
32. ES Hwang S DeVries KL Chew DH Moore 2nd K Kerlikowske A Thor BM Ljung FM Waldman 2004 Patterns of chromosomal alterations in breast ductal carcinoma in situ Clin Cancer Res 10 5160 5167 1:CAS:528:DC%2BD2cXmtlSitbY%3D 10.1158/1078-0432.CCR-04-0165 15297420 (Pubitemid 39099791)
33. A Adeyinka E Emberley Y Niu L Snell LC Murphy H Sowter CC Wykoff AL Harris PH Watson 2002 Analysis of gene expression in ductal carcinoma in situ of the breast Clin Cancer Res 8 3788 3795 1:CAS:528:DC%2BD38XpslCjt7Y%3D 12473591
34. XJ Ma R Salunga JT Tuggle J Gaudet E Enright P McQuary T Payette M Pistone K Stecker BM Zhang YX Zhou H Varnholt B Smith M Gadd E Chatfield J Kessler TM Baer MG Erlander DC Sgroi 2003 Gene expression profiles of human breast cancer progression Proc Natl Acad Sci USA 100 5974 5979 1:CAS:528:DC%2BD3sXjvFOlt78%3D 10.1073/pnas.0931261100 12714683 (Pubitemid 36576916)
35. W McGinnis R Krumlauf 1992 Homeobox genes and axial patterning Cell 68 283 302 1:CAS:528:DyaK38XhtVShs7o%3D 10.1016/0092-8674(92)90471-N 1346368
36. MC Chu FB Selam HS Taylor 2004 HOXA10 regulates p53 expression and matrigel invasion in human breast cancer cells Cancer Biol Ther 3 568 572 1:CAS:528:DC%2BD2MXhtF2ktL0%3D 15044858
37. E Klopocki G Kristiansen PJ Wild I Klaman E Castanos-Velez G Singer R Stöhr R Simon G Sauter H Leibiger L Essers B Weber K Hermann A Rosenthal A Hartmann E Dahl 2004 Loss of SFRP1 is associated with breast cancer progression and poor prognosis in early stage tumors Int J Oncol 25 641 649 1:CAS:528:DC%2BD2cXnt1Ohu7Y%3D 15289865
38. J Kwong J Lee K Wong X Zhou DTW Wong K Lo WR Welch RS Berkowitz SC Mok 2006 Candidate tumor-suppressor gene DLEC1 is frequently downregulated by promoter hypermethylation and histone hypoacetylation in human epithelial ovarian cancer Neoplasia 8 268 278 1:CAS:528:DC%2BD28XovVKlu7s%3D 10.1593/neo.05502 16756719
39. TJ Seng N Currey WA Cooper C Lee C Chan L Horvath RL Sutherland C Kennedy B McCaughan MRJ Kohonen-Corish 2008 DLEC1 and MLH1 promoter methylation are associated with poor prognosis in non-small cell lung carcinoma Br J Cancer 99 375 382 1:CAS:528:DC%2BD1cXosFWntrg%3D 10.1038/sj.bjc.6604452 18594535
40. J Ying FF Poon J Yu H Geng AHY Wong G Qiu HK Goh SY Rha L Tian ATC Chan JJY Sung Q Tao 2009 DLEC1 is a functional 3p22.3 tumour suppressor silenced by promoter CpG methylation in colon and gastric cancers Br J Cancer 100 663 669 1:CAS:528:DC%2BD1MXit1Oktbk%3D 10.1038/sj.bjc.6604888 19156137
41. C Ferrario P Lavagni M Gariboldi C Miranda M Losa L Cleris F Formelli S Pilotti MA Pierotti A Greco 2008 Metallothionein 1G acts as an oncosupressor in papillary thyroid carcinoma Lab Invest 88 474 481 1:CAS:528:DC%2BD1cXltVGrs7s%3D 10.1038/labinvest.2008.17 18332874 (Pubitemid 351581452)
42. Y Huang A de la Chapelle NS Pellegata 2003 Hypermethylation, but not LOH, is associated with the low expression of MT1G and CRABP1 in papillary thyroid carcinoma Int J Cancer 104 735 744 1:CAS:528:DC%2BD3sXjtVWqtrw%3D 10.1002/ijc.11006 12640681 (Pubitemid 36418511)
43. R Henrique C Jerónimo MO Hoque S Nomoto AL Carvalho VL Costa J Oliveira MR Teixeira C Lopes D Sidransky 2005 MT1G hypermethylation is associated with higher tumor stage in prostate cancer Cancer Epidemiol Biomark Prev 14 1274 1278 1:CAS:528:DC%2BD2MXktFCktL8%3D 10.1158/1055-9965.EPI-04-0659 (Pubitemid 40656480)
44. GS Dalgin M Drever T Williams T King C DeLisi LS Liou 2008 Identification of novel epigenetic markers for clear cell renal cell carcinoma J Urol 180 1126 1130 1:CAS:528:DC%2BD1cXhtVKmsbbN 10.1016/j.juro.2008.04.137 18639284
45. W Feng L Shen S Wen DG Rosen J Jelinek X Hu S Huan M Huang J Liu AA Sahin KK Hunt RC Bast Y Shen JJ Issa Y Yu 2007 Correlation between CpG methylation profiles and hormone receptor status in breast cancers Breast Cancer Res 9 R57 10.1186/bcr1762 17764565 (Pubitemid 350187466)
46. E Sunami M Shinozaki M Sim SL Nguyen A Vu AE Giuliano DSB Hoon 2008 Estrogen receptor and HER2/neu status affect epigenetic differences of tumor-related genes in primary breast tumors Breast Cancer Res 10 R46 10.1186/bcr2098 18485221
47. JS Lee MJ Fackler JH Lee C Choi MH Park JH Yoon Z Zhang S Sukumar 2010 Basal-like breast cancer displays distinct patterns of promoter methylation Cancer Biol Ther 9 1017 1024 1:CAS:528:DC%2BC3cXhtlKgt73E 10.4161/cbt.9.12.11804 20505321